For Physicians
Welcome to Otogenetics, your partner in advanced genetic testing.
Physicians Introduction
We specialize in providing accurate and reliable next-generation sequencing for precise prenatal screening and inherited cancer screening. Our cutting-edge technology and dedicated team ensure high-quality results, empowering you to make informed clinical decisions for your patients. Trust Otogenetics for comprehensive genetic insights that enhance patient care.
GxVISION® Carrier Screening
Carrier screening is genetic testing that determines whether an asymptomatic person has a genetic mutation or abnormalities associated with a particular disorder that may be passed on to children.
Our Carrier Screening Gene Tests are associated with heritable disorders including 32 core and 26 secondary conditions identified by American College of Medical Genetics (ACMG) and American Congress of Obstetricians and Gynecologists (ACOG), and recommended by US Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children for screening.
EnVISION Non-Invasive Prenatal® Screening
Advancements in genetic testing have enabled the most accurate and sensitive detection of fetal chromosomal abnormalities via the analysis of cell free DNA (cfDNA) derived from fetal placenta in the maternal blood. The American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal Fetal Medicine (SMFM) jointly and specifically stated in the new clinical management guidelines (ACOG Practice Bulletin #226, 2020) that NIPT is the most sensitive and specific screening test for common fetal aneuploidies, and that all pregnant women, regardless of age or other risk factors, should be offered prenatal screening for fetal chromosomal abnormalities.
Inherited Cancer (GxVision®)
Otogenetics Comprehensive Panel addresses the overlapping genes found in multiple types of hereditary cancers. The utility of Next Generation Sequencing, the advanced genetic testing technology, allows the best possible coverage and detection of genetic variations associated with cancers and cancer risk.
GxVISION® Congenital Hearing Loss
Worldwide, 1-2 per 1000 babies are born deaf (CDC Data and Statistics). Based on the recent CDC study from 50 states spanning 2015-2017, hearing loss is the most common congenital condition present at birth, more than the most common newborn dry blood spot (DBS) screened conditions (primary Congenital Hypothyroidism, Sickle Cell Disease and Cystic Fibrosis) and critical congenital heart defects (CHD) combined.
FAQ’s Billing & Insurance FAQs
Every patient should have access to highly accurate and affordable genetic testing. Otogenetics is committed to work with each patient to reach payment solutions. These may include:
- Working with your insurance provider to verify coverage.
- Flexible payment options billed over several months.
- Financial assistance for patients who qualify.
We encourage patients to call us for all billing questions, and to discuss payment solutions.
Please call us toll free at 1-855-686-4363, option 1.
Otogenetics is committed to working with patients to ensure that everyone has access to testing without financial burden.
- Medicaid patients will NOT have patient out of pocket responsibility.
- We treat all out-of-network claims as if they are in-network.
- We will work with all insurers (primary and secondary policies) to maximize your qualified coverage.
Otogenetics testing service is covered by many insurance plans, the exact amount your patients owe may vary based on their individual plan and financial situation.
Here is our commitment to your patients regarding costs:
- We will reach out to your patient if we estimate their cost could be more than $50 (the average out of pocket Otogenetics patients pay).
- We will discuss the estimate with your patients, and review their affordability.
Your patient may receive information from their insurer, known as an Explanation of Benefits (EOB), regarding the test they received from Otogenetics.
An EOB from your patient’s insurer is NOT A BILL.
A bill for the test(s) provided by Otogenetics comes ONLY from Otogenetics.
If there is any patient out of pocket cost after Otogenetics has exhausted all options for reimbursement coverage and financial assistance, Otogenetics will reach out to your patient.
Next Steps
To get started, talk to your healthcare provider about requesting a prenatal and/or carrier screen.
Your healthcare provider will take a blood draw or buccal (cheek) swab sample and send it to our lab.
Otogenetics will analyze your DNA sample using our state-of-the-art technologies.
Once your screen is complete, your healthcare provider or a genetic counselor from Otogenetics may contact you to explain your results and answer any questions you have.